J&J’s Ashita Batavia on advancing oncology clinical-trials with data

McKinsey April 8, 2025
Alex Devereson with Meredith Langstaff and Navraj Nagra

Ashita Batavia, head of hematology and oncology data sciences, R&D, at Johnson & Johnson Innovative Medicine, discusses how data can advance clinical trials, drug development, and prescreening.

In this episode of Eureka!, McKinsey’s podcast on innovation in life sciences R&D, hosts Navraj Nagra, Alex Devereson, and Meredith Langstaff speak to Ashita Batavia, head of hematology and oncology data sciences, R&D, at Johnson & Johnson Innovative Medicine (J&J). They discuss how real-world data can better inform clinical trials, the shifts in mindsets and capabilities needed to support AI in biopharma, and how to navigate the complexity of clinical trials with more-pragmatic trial designs. An edited version of their conversation follows.

The need for more, higher-quality data

Alex Devereson: There’s been a...

Today's Sponsors

Today's Sponsor